KMT2A and acute myeloid leukemia: The largest differences compared to normal myHPCs were recorded for this marker in the inv(16) AML group (higher intensity of expression) as revealed by the viSNE dot plots on the nodes containing a significantly increased number of events in inv(16) AML (Figure 3B; P = 0.0217), but also between MLL AML blasts (decreased expression) compared with their nearest normal myHPCs (Figure 4B; P = 0.0429).